According to Mesoblast 's latest financial reports the company's current EPS (TTM) is $55.95. In 2022 the company made an earnings per share (EPS) of $50.74 an increase over its 2021 EPS that were of -$1.06.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $51.04 | 0.59% |
2022 | $50.74 | -4897.44% |
2021 | -$1.06 | -13.08% |
2020 | -$1.22 | 17.91% |
2019 | -$1.03 | -17.18% |
2018 | -$1.25 | 141.13% |
2017 | -$0.52 | 422.52% |
2016 | -$0.09888 | -94.58% |
2015 | -$1.83 |